Open AccessNational Vaccine Policy: ethical equity issues
Author(s) -
Jayakrishnan Thayyil
Publication year - 2013
Publication title -
indian journal of medical ethics/indian journal of medical ethics (online)
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.204
H-Index - 16
eISSN - 0975-5691
pISSN - 0974-8466
DOI - 10.20529/ijme.2013.054
Subject(s) - hpv vaccines , health policy , vaccination , political science , public health , rotavirus vaccine , immunization , medicine , rotavirus , virology , immunology , hpv infection , virus , nursing , cervical cancer , cancer , antigen
The ministry of health and family welfare published the national vaccination policy in April 2011. The policy document drew severe criticism from several public health experts. A review of the print and web-based literature on the national vaccine policy was done and the issues of ethics and equity involved in introducing new vaccines under the Universal Immunisation Programme (UIP) were studied. The average coverage of the UIP vaccines at the national level is below 50%. Despite this, the policy document did not state any concrete strategy for increasing the coverage. The main stumbling block for evidence-based vaccine policy in India is the lack of reliable epidemiological data, which makes it difficult for the National Technical Advisory Group on Immunisation to offer sound technical advice to the government. No attempts have been made to prioritise diseases or the selection of vaccines. The policy suggests the introduction of the following vaccines in the UIP: Haemophilus influenzae type b, pneumococcal vaccine, rotavirus vaccines and human papillomavirus (HPV). This selection is on the grounds of the vaccines' availability, not on the basis of epidemiological evidence or proven cost-effectiveness. This is a critical review of the current vaccination policy and the move to include the rotavirus and HPV vaccines in the UIP.